A newly developed male contraceptive, styrene maleic anhydride (SMA), was injected in the vas deferens of male rhesus monkeys for safety evaluation at the dose of 100 mg (contraceptive dose, CD), 250 mg (CD x 2.5) and 500 mg (CD x 5.0), and the monkeys were kept under observation for one year. The observed behavioural, haematological, biochemical and histopathological parameters in treated monkeys were comparable to controls. The results suggest the polymer SMA to be safe up to 5 times CD in monkeys.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0010-7824(90)90021-mDOI Listing

Publication Analysis

Top Keywords

styrene maleic
8
maleic anhydride
8
male contraceptive
8
rhesus monkeys
8
monkeys
5
chronic toxicity
4
toxicity styrene
4
anhydride male
4
contraceptive rhesus
4
monkeys macaca
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!